CORCEPT THERAPEUTICS INC — Director's Dealing 2016

Dec 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-12-12

Reporting Person: Tammenoms Bakker Juliet (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-12	Common Stock	J	204210	$0.00	Acquired	204210	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10740720	Indirect
Common Stock	215282	Indirect

Footnotes

F1: On November 28, 2016, Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA") completed a pro rata distribution of shares of common stock of the Issuer to its partners for no consideration. Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP and LCA, received a pro rata allocation of the distributed shares in accordance with its ownership, and on December 12, 2016, further distributed its allocation to its managing members. Juliet Tammenoms Bakker, as a managing member of Longitude Capital, acquired the shares noted in this Form through such distribution.

F2: Reflects holdings of shares of common stock of the Issuer held of record by LVP and LCA. Ms. Bakker disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of her pecuniary interest therein.

F3: The holdings in this Form 4 have been adjusted to reflect a previous transfer of 94,129 shares from LVP to LCA.